The ROE as of April 2025 (TTM) for UCB SA (UCBJF) is 2.53%

According to UCB SA’s latest financial reports and current stock price. The company's current ROE is 2.53%. This represents a change of 65.29% compared to the average of 1.53% of the last 4 quarters.

UCB SA (UCBJF) Historical ROE (quarterly & annually)

How has UCBJF ROE performed in the past?

The mean historical ROE of UCB SA over the last ten years is 9.26%. The current 2.53% ROE has changed -72.69% with respect to the historical average. Over the past ten years (40 quarters), UCBJF's ROE was at its highest in in the June 2018 quarter at 9.17%. The ROE was at its lowest in in the June 2005 quarter at 0%.

UCB SA (UCBJF) ROE by Quarter and Year

Discovering the peaks and valleys of UCB SA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

UCB SA (UCBJF) Average ROE

How has UCBJF ROE performed in the past?

The current ROE of UCB SA (UCBJF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

UCB SA (UCBJF) ROE vs. Peers

How is UCBJF’s ROE compared to its peers?

UCB SA’s ROE is greater than Bolt Biotherapeutics, Inc. (-79.08%), less than Calithera Biosciences, Inc. (8.01%), greater than Cara Therapeutics, Inc. (-755.61%), greater than Arcus Biosciences, Inc. (-47.32%), greater than Senti Biosciences, Inc. (-148.82%), less than ZIVO Bioscience, Inc. (747.50%), greater than Cadrenal Therapeutics, Inc. Common Stock (-202.53%), less than Foghorn Therapeutics Inc. (186.66%), greater than Quoin Pharmaceuticals, Ltd. (-0.39%), less than Fresh2 Group Limited (1.12%), greater than Adagene Inc. (-41.72%), less than Kineta, Inc. (934.78%), greater than Ikena Oncology, Inc. (-35.27%), greater than Axcella Health Inc. (-620.40%), less than Verrica Pharmaceuticals Inc. (549.95%), less than Onconova Therapeutics, Inc. (500.19%), greater than Hoth Therapeutics, Inc. (-103.83%), greater than Acasti Pharma Inc. (-18.84%), greater than Vincerx Pharma, Inc. (-451.26%), greater than Jaguar Health, Inc. (-283.78%), greater than iBio, Inc. (-99.20%), greater than GeoVax Labs, Inc. (-884.88%), greater than Ocugen, Inc. (-184.09%),

Build a custom stock screener for UCB SA (UCBJF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like UCB SA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

UCB SA (UCBJF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like UCB SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.